Skip to content

Cognitive Behavioral Therapy for Depression in Parkinson's Disease

Depression in Parkinson's Disease: A Pilot Project Using Cognitive Behavioral Therapy (CBT) to Improve Depression and Coping

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00810628
Enrollment
12
Registered
2008-12-18
Start date
2009-01-31
Completion date
2009-12-31
Last updated
2014-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression, Parkinson's Disease

Keywords

Parkinson's disease, depression, Parkinson's disease with mild to moderate depression.

Brief summary

The purpose of this pilot program is to develop and evaluate a new treatment program for depression in Parkinson's disease (PD). The treatment uses Cognitive Behavior Therapy(CBT)to teach patients how to become more aware of their thoughts and feelings and to change thinking patterns and behaviors that may be related to depressive symptoms. This is the first time that this treatment has been used in a group setting for depression in PD. Target population is patients in the Movement Disorders Clinic at Oregon Health & Science University who have Parkinson's disease and mild to moderate depression.

Interventions

BEHAVIORALCognitive Behavioral Therapy

Individual interviews and group discussion/training.

Sponsors

National Parkinson Foundation
CollaboratorOTHER
Oregon Health and Science University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
35 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Parkinson's disease, mild to moderate depression, seen at Oregon Health & Science University

Exclusion criteria

* Suicidal * Cognitive impairment with MOCA \<26

Design outcomes

Primary

MeasureTime frame
The change in CESD scoreBaseline and 10 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026